Harneet Singh Rishi

Scientist-Engineer-Data Nerd | #Data at KariusDx, NovomeBio | PhD @UCBerkeley #ArkinLab | #F1 #Lakers fan

[Harneet Singh Rishi @rishihs]

@vivek_mutalik @srikosuri @vivek_mutalik requesting parathas be on the menu too!

[Harneet Singh Rishi @rishihs]

Ease-of-use of spreadsheets + database-inspired structure + reproducible analysis and reporting = 😎^ 🙌

Excited to see the release of Tabulous from an amazingly talented team I've had the pleasure of working with in the past!

[Will DeLoache @wideloache]

https://t.co/dHNaWDrRtW

[Harneet Singh Rishi @rishihs]

Christmas came early this year with @_hex_tech releasing one of the most feature-packed (and funniest) launches I’ve ever seen. Kudos to the team for continuing to push the envelope for analytics/DS tooling. Improved AI workflows + multi-tab app support + 🏎️ upgrades = 😎^🔥

[Hex @_hex_tech]

Tomorrow's Hex 3.0 launch event features Barry (CEO), Gerald (head of aerospace materials division), Olivia (AI engineer), Izzy (missing in employee db?) and more great folks from our team.
🔴 Live on Thursday at 10am PT, tune in: https://t.co/EyFfGzEJD4

[Ben Adler @ben_a_adler]

I’m really excited to share our new pre-print “Genome-wide Characterization of Diverse Bacteriophages Enabled by RNA-Binding CRISPRi”, with co-first author Muntathar Al-Shimary @doudna_lab and the newly-minted @bradyfcress lab!
https://t.co/KWg8FAUhLJ
🧵🧵
1/

[Vivek Mutalik @vivek_mutalik]

Super thrilled to announce that we secured BRaVE initiative funding to establish "Phage Foundry" with a dream team!! 🥳 Aim is to develop a foundational platform that integrates many aspects of phage research and rapidly design countermeasures for AMR pathogens.

[Alfredo Andere @AlfredoAndere]

Biological data is growing exponentially.

It’s difficult to reconcile and work with all of it.

That’s why we’re building a Cloud for Biology.

https://t.co/pfJV7dUXhq

[Harneet Singh Rishi @rishihs]

When you think about a feature suggestion for @_hex_tech, start writing the email, and then see you just got an email about how they’re already doing it 🤯🤩😎

[Hex @_hex_tech]

Today we are launching a private beta of 🔮 Hex Magic 🪄 AI-powered tools to help humans do amazing things with data.

Check it out and sign up for the waitlist here: https://t.co/0lCehA9jvV

[Novome Biotechnologies @novomebio]

#News: Excited to share we’ve secured $43.5 million in our Series B financing to advance our ongoing Phase 2a clinical trial in #hyperoxaluria and pipeline of #GEMMs candidates for #IBD. Learn more: https://t.co/DrY9hgxLGu #celltherapy #livingmedicines

[Harneet Singh Rishi @rishihs]

@_hex_tech Congrats @_hex_tech! 👏🎉

[Hex @_hex_tech]

💸 We raised a Series B to hire more amazing people, ship even more great features, and help data teams go from analyzing data to ✨creating knowledge✨.

Read more about where we're going and why on the blog: https://t.co/mXVWWcZFY8

[Hex @_hex_tech]

Introducing the Knowledge Library, a new set of workflows in Hex that empower teams to create knowledge from their work. https://t.co/mSDwkplr60

[Barry McCardel @barrald]

High-impact data work isn’t about churning out analysis; it’s about creating ⚡️knowledge⚡️

This is why I’m so excited about the new Knowledge Library features in @_hex_tech! https://t.co/eDqPwaguF3

A 🧵:

[Modern Data Stack @moderndatastack]

🚀 MDS is live on @ProductHunt

It's a big day for us! Big thanks to @kevinwdavid for hunting us.

We'd love to get your support and hear your feedback in the comments. Thank you so much for your love since the very inception of MDS!

Check us out here: https://t.co/Ja4qBDCstc

[Harneet Singh Rishi @rishihs]

Congrats @ben_a_adler!

[Ben Adler @ben_a_adler]

Our Salmonella phage-host interaction paper (and my first-first author) is finally out! Please check it our if you're interested in Salmonella, phage, or high-throughput genetic screens!

Lots of time, effort, and sequencing went into this one 😅

[Harneet Singh Rishi @rishihs]

An exciting milestone for the @novomebio team as we report promising results from our Phase 1 demonstrating robust and controllable engraftment of our #GEMMs platform in humans - the first time for a therapeutically engineered microbe in the human GI tract! #synbio #celltherapy

[Novome Biotechnologies @novomebio]

#News: Excited to share positive Phase 1 results of our orally-administered #GEMM, NOV-001, which produced high levels of engraftment of our engineered strain in the GI tract. Learn more here: https://t.co/Mm76N88lMP #celltherapy #IBD #livingmedicines

[Harneet Singh Rishi @rishihs]

Exciting news for Novome today as we announce our partnership with @genentech for inflammatory bowel disease #IBD! Read more about it 👇

[Novome Biotechnologies @novomebio]

#News: Exciting day here as we enter a collaboration with @Genentech to leverage our #GEMMs platform to develop targets against inflammatory bowel disease. Learn more here: https://t.co/0UyMrcoH2m #celltherapy #IBD #livingmedicines

[Harneet Singh Rishi @rishihs]

An exciting milestone for @novomebio as we dose our first subject ever in our Ph1 trial on the path to a treatment for enteric #hyperoxaluria!

[Novome Biotechnologies @novomebio]

#News: We’ve dosed our first subject in the Phase 1 clinical trial evaluating our once-daily oral #GEMM candidate for the potential treatment of enteric #hyperoxaluria. https://t.co/477ybKdenT #GEMMs #celltherapy #gutmicrobiome #livingmedicines

[Scribe Therapeutics @scribetx]

1/ We’re excited to announce the completion of our $100M Series B financing to further develop our ”CRISPR by Design” platform and pipeline of #CRISPR-based in vivo genetic medicines that treat the underlying cause of disease. https://t.co/g34FRhnQYg

[Harneet Singh Rishi @rishihs]

Congratulations Hualan and team! We started reading this at Novome the day it came out!

[Hualan liu @lanlanliu2]

A great experience working on this project, and big thanks to our wonderful collaborators. @DeutschbauerLab @AdamArkinLab, @PTurnbaugh lab, Christopher J Petzold lab @JBEI,and Kerwyn Casey Huang lab @Stanford.
https://t.co/ZoT0dcdgMz

[Harneet Singh Rishi @rishihs]

Congrats Sean and team! Looking forward to reading it in depth!

[Sean Carim @carimfraiche]

It's a rare and special thing to see your work reach a satisfying conclusion. @AzadehAshley, @AlexeyKazakov8, @vivek_mutalik, @AdamArkinLab, we did it! Our study on tailocins appears in the ISME Journal as of this week. https://t.co/EtvAUAGmwM